Enfusion, Inc.
ENFN
$9.67
$0.030.31%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.87M | 46.11M | 43.89M | 42.56M | 40.74M |
| Total Other Revenue | 186.00K | 376.00K | 472.00K | 166.00K | 229.00K |
| Total Revenue | 48.05M | 46.49M | 44.36M | 42.72M | 40.97M |
| Cost of Revenue | 16.17M | 15.62M | 14.51M | 14.21M | 13.30M |
| Gross Profit | 31.88M | 30.86M | 29.85M | 28.51M | 27.67M |
| SG&A Expenses | 26.44M | 22.67M | 22.22M | 21.60M | 18.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.17M | 44.35M | 41.67M | 40.28M | 36.29M |
| Operating Income | -1.11M | 2.13M | 2.69M | 2.45M | 4.68M |
| Income Before Tax | -878.00K | 2.18M | 3.03M | 1.19M | 5.09M |
| Income Tax Expenses | -117.00K | 1.28M | 367.00K | 188.00K | 396.00K |
| Earnings from Continuing Operations | -761.00K | 900.00K | 2.66M | 998.00K | 4.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 222.00K | -277.00K | -833.00K | -369.00K | -1.75M |
| Net Income | -539.00K | 623.00K | 1.83M | 629.00K | 2.95M |
| EBIT | -1.11M | 2.13M | 2.69M | 2.45M | 4.68M |
| EBITDA | 461.00K | 4.65M | 4.31M | 3.73M | 5.85M |
| EPS Basic | -0.01 | 0.00 | 0.02 | 0.01 | 0.04 |
| Normalized Basic EPS | 0.00 | 0.01 | 0.01 | 0.00 | 0.02 |
| EPS Diluted | -0.01 | 0.00 | 0.02 | 0.01 | 0.04 |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 89.51M | 88.28M | 87.74M | 88.31M | 88.86M |
| Average Diluted Shares Outstanding | 89.51M | 127.77M | 127.84M | 129.86M | 132.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
